The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"